Individual maternal and child exposure to antibiotics in hospital - a national population-based validation study

C Almqvist1, A K Örtqvist, T Gong

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.

Insights

Early life antibiotic exposure is linked to future health. This study quantises antibiotic use in Swedish hospitals for pregnant women and children up to five years old, correlating diagnoses with prescriptions.

Area of Science:

  • Pediatric Health
  • Infectious Disease Management
  • Pharmacovigilance

Background:

  • Antibiotic exposure in early life is a growing concern for long-term health.
  • While outpatient antibiotic use is common, inpatient exposure, especially in vulnerable populations, requires detailed investigation.
  • Understanding the link between specific hospital diagnoses and antibiotic prescriptions is crucial for public health.

Purpose of the Study:

  • To quantify individual antibiotic exposure in relation to specific inpatient diagnoses among pregnant women and children (birth to 5 years) in Sweden.
  • To establish a baseline for antibiotic prescribing patterns in a key demographic for future research.
  • To inform strategies for optimizing antibiotic stewardship in pediatric and maternal inpatient settings.

Main Methods:

  • Retrospective analysis of inpatient data from the Swedish National Patient Register (July 2005 - November 2011).
  • Inclusion of pregnant women and children (birth to 5 years) with infectious and common inpatient diagnoses.
  • Manual review of medical records from a random sample of individuals to determine antibiotic prescriptions linked to diagnoses.

Main Results:

  • Antibiotic treatment was observed in 25% of premature infants.
  • Children aged 1-5 with bacterial infections received antibiotics more frequently (62.4-90.6%) than those with viral infections (6.3-22.2%).
  • Women undergoing Cesarean sections had higher antibiotic use (40.1%) compared to vaginal deliveries (11.1%).

Conclusions:

  • This study provides the first detailed quantification of antibiotic treatment for specific inpatient diagnoses in Swedish mothers and young children.
  • The findings establish a critical baseline for antibiotic use in this population.
  • This data is essential for future research on the long-term health impacts of early-life antibiotic exposure and for refining antibiotic stewardship programs.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
46
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
158
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
50
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K